Open Access. Powered by Scholars. Published by Universities.®
- Discipline
-
- Medicine and Health Sciences (252)
- Life Sciences (115)
- Public Health (95)
- Medical Sciences (79)
- Medical Specialties (74)
-
- Immunology and Infectious Disease (59)
- Diseases (50)
- Infectious Disease (36)
- Law (35)
- Nursing (34)
- Virus Diseases (33)
- Medical Immunology (31)
- Microbiology (27)
- Social and Behavioral Sciences (27)
- Epidemiology (24)
- Community Health and Preventive Medicine (23)
- Health Law and Policy (23)
- Influenza Virus Vaccines (23)
- Immunology of Infectious Disease (22)
- Veterinary Medicine (21)
- Biological Phenomena, Cell Phenomena, and Immunity (18)
- Virology (18)
- Public Health Education and Promotion (17)
- Physical Sciences and Mathematics (16)
- Animal Sciences (14)
- Genetics and Genomics (14)
- Biology (13)
- Influenza Humans (13)
- Bioinformatics (12)
- Cell and Developmental Biology (12)
- Institution
-
- University of Nebraska - Lincoln (36)
- The Texas Medical Center Library (32)
- University of Kentucky (13)
- TÜBİTAK (12)
- Brigham Young University (11)
-
- Saint Louis University School of Law (10)
- Thomas Jefferson University (10)
- Walden University (10)
- Aga Khan University (8)
- Louisiana State University (8)
- University of New Mexico (8)
- University of Arkansas, Fayetteville (7)
- University of South Florida (7)
- Georgia Southern University (6)
- The University of Southern Mississippi (6)
- University of Louisville (6)
- University of South Carolina (6)
- Liberty University (5)
- University of Connecticut (5)
- University of Mississippi (5)
- University of Texas at El Paso (5)
- Villanova University Charles Widger School of Law (5)
- City University of New York (CUNY) (4)
- Universitas Indonesia (4)
- University of New Hampshire (4)
- University of Texas Rio Grande Valley (4)
- Utah State University (4)
- Barry University School of Law (3)
- Dartmouth College (3)
- Loyola University Chicago (3)
- Publication Year
- Publication
-
- Faculty Publications (20)
- Faculty, Staff and Students Publications (14)
- Faculty, Staff and Student Publications (11)
- Walden Dissertations and Doctoral Studies (10)
- All Faculty Scholarship (9)
-
- Nebraska Center for Virology: Faculty Publications (9)
- Theses and Dissertations (8)
- Electronic Theses and Dissertations (7)
- Turkish Journal of Medical Sciences (7)
- United States Department of Agriculture Wildlife Services: Staff Publications (7)
- Biomedical Sciences ETDs (6)
- Department of Microbiology and Immunology Faculty Papers (6)
- Graduate Theses and Dissertations (6)
- Honors Theses (6)
- Faculty Scholarship (5)
- Open Access Theses & Dissertations (5)
- USF Tampa Graduate Theses and Dissertations (5)
- Dissertations (4)
- Master's Theses (4)
- Publications (4)
- Senior Honors Theses (4)
- Student Works (4)
- Turkish Journal of Veterinary & Animal Sciences (4)
- All ETDs from UAB (3)
- Articles (3)
- Dartmouth Scholarship (3)
- Doctor of Nursing Practice Final Manuscripts (3)
- Graduate Student Theses, Dissertations, & Professional Papers (3)
- Graduate Theses, Dissertations, and Problem Reports (ETD) (3)
- Honors College Theses (3)
- Publication Type
Articles 271 - 300 of 402
Full-Text Articles in Entire DC Network
Readyvax: A New Mobile Vaccine Information App, Robert A. Bednarczyk, Paula M. Frew, Daniel A. Salmon, Ellen Whitney, Saad B. Omer
Readyvax: A New Mobile Vaccine Information App, Robert A. Bednarczyk, Paula M. Frew, Daniel A. Salmon, Ellen Whitney, Saad B. Omer
Environmental & Global Health Faculty Research
Vaccine information of varying quality is available through many different sources. We describe the creation, release and utilization of ReadyVax, a new mobile smartphone app providing access to trustworthy, evidence-based vaccine information for a target audience of healthcare providers, pharmacists, and patients (including parents of children). We describe the information content and technical development of ReadyVax. Between the hard launch of the app on February 12, 2015 and October 8, 2016, the app has been downloaded by 5,142 unique users, with 6,841 total app sessions initiated, comprising a total of 15,491 screen views (2.3 screens/session on average). ReadyVax has been …
Best Practice For Treatment Of Vaccination Side-Effects With Antipyretic And Analgesic Medications, Lacey M. Eden, Meridith G. Lind, Karlen E. Luthy
Best Practice For Treatment Of Vaccination Side-Effects With Antipyretic And Analgesic Medications, Lacey M. Eden, Meridith G. Lind, Karlen E. Luthy
Student Works
Nurse Practitioners (NPs) are on the frontlines providing parental education regarding vaccines. While there are several reasons for vaccine hesitancy, the potential side-effects of vaccine administration, such as pain and/or elevated temperature, are often cited as a parental concern. According to research, prophylactic administration of an antipyretic/analgesic medication, such as acetaminophen, reduces vaccine side-effects when administered prior to or at the time of vaccination. Additionally, the evidence that prophylactic administration of antipyretic/analgesic medication decreases antibody response to vaccinations is insufficient at this time. Thus, NPs should reassure parents that an antipyretic/analgesic medication can be administered prior to or at the …
In Silico Cd4+, Cd8+ T-Cell And B-Cell Immunity Associated Immunogenic Epitope Prediction And Hla Distribution Analysis Of Zika Virus, Essam Mohammed Janahi, Anupam Dhasmana, Vandana Srivastava, Aditya Narayan Sarangi, Sana Raza, Jamal M. Arif, Madan Lal Brahma Bhatt, Mohtashim Lohani, Mohammaed Y. Areeshi, Anand Murari Saxena, Shafiul Haque
In Silico Cd4+, Cd8+ T-Cell And B-Cell Immunity Associated Immunogenic Epitope Prediction And Hla Distribution Analysis Of Zika Virus, Essam Mohammed Janahi, Anupam Dhasmana, Vandana Srivastava, Aditya Narayan Sarangi, Sana Raza, Jamal M. Arif, Madan Lal Brahma Bhatt, Mohtashim Lohani, Mohammaed Y. Areeshi, Anand Murari Saxena, Shafiul Haque
School of Medicine Publications
Zika virus (ZIKV) is a mosquito-borne flavivirus distributed all over Africa, South America and Asia. The infection with the virus may cause acute febrile sickness that clinically resembles dengue fever, yet there is no vaccine, no satisfactory treatment, and no means of evaluating the risk of the disease or prognosis in the infected people. In the present study, the efficacy of the host's immune response in reducing the risk of infectious diseases was taken into account to carry out immuno-informatics driven epitope screening strategy of vaccine candidates against ZIKV. In this study, HLA distribution analysis was done to ensure the …
Varicella Seroepidemiology In United States Air Force Recruits: A Retrospective Cohort Study Comparing Immunogenicity Of Varicella Vaccination And Natural Infection, Joshua R. Duncan, Catherine T. Witkop, Bryant J. Webber, Amy A. Costello
Varicella Seroepidemiology In United States Air Force Recruits: A Retrospective Cohort Study Comparing Immunogenicity Of Varicella Vaccination And Natural Infection, Joshua R. Duncan, Catherine T. Witkop, Bryant J. Webber, Amy A. Costello
Uniformed Services University of the Health Sciences
Background/Objectives: Infection with varicella zoster virus (VZV) produces lifelong immunity, but duration of post-vaccination immunity has not been established. The purpose of this study is to determine if a difference exists in the long-term seropositivity of anti-VZV antibodies in a cohort of young adults who were vaccinated against varicella as compared to a similar cohort with a history of chickenpox disease, and to determine which variables best predict waning seropositivity following varicella vaccination.
Methods: This retrospective cohort study captures immunization and serology data from approximately 10,000 recruits who entered basic military training between January 1, 2008, and December 31, 2015, …
A Stinging Effect: The Legal Implications Biting Into The Effects Of The Zika Virus, Keanu Bader Mr
A Stinging Effect: The Legal Implications Biting Into The Effects Of The Zika Virus, Keanu Bader Mr
Honors Undergraduate Theses
People are afraid of contagious diseases. The thought that disease can spread throughout an entire population tends to make people wary of their interactions with their surrounding environment. Hearing about, or even seeing pictures of mosquitoes can make people squeamish or even stimulate an itch. Throughout the ages, the reaction to contagious diseases has been to quarantine and isolate. From the bubonic plague to the 1918 “Spanish” flu, the protocol was to quarantine those infected and isolate the rest. It may be this practice that inspired such precautions be taken by the public. Often these precautions are not warrantless and …
Tryptophan 375 Stabilizes The Outer-Domain Core Of Gp120 For Hiv Vaccine Immunogen Design, Duoyi Hu, Dane Bowder, Wenzhong Wei, Jesse Thompson, Mark A. Wilson, Shi-Hua Xiang
Tryptophan 375 Stabilizes The Outer-Domain Core Of Gp120 For Hiv Vaccine Immunogen Design, Duoyi Hu, Dane Bowder, Wenzhong Wei, Jesse Thompson, Mark A. Wilson, Shi-Hua Xiang
Nebraska Center for Virology: Faculty Publications
The outer-domain core of gp120 may serve as a better HIV vaccine immunogen than the full-length gp120 because of its greater stability and immunogenicity. In our previous report, we introduced two disulfide bonds to the outer-domain core of gp120 to fix its conformation into a CD4-bound state, which resulted in a significant increase in its immunogenicity when compared to the wild-type outer-domain core. In this report, to further improve the immunogenicity of the outer-domain core based immunogen, we have introduced a Tryptophan residue at gp120 amino acid sequence position 375 (375S/W). Our data from immunized guinea pigs indeed shows a …
A Cost-Effectiveness Study Of The Quadrivalent Hpv6/11/16/18 Vaccination In A Two-Dose Scheme In Girls Of 9-11 Years Old Compared To Bivalent Hpv 16/18 Vaccination In Ecuador And Challenges For Public Health And Screening, Maria-Isabel Roldos, Isabel Espinosa, Amit Kulkarni, Matthew Pillsbury, Andrew Pavelyev, Homero A. Monsanto, Diego Guarin, Miguel Cashat-Cruz
A Cost-Effectiveness Study Of The Quadrivalent Hpv6/11/16/18 Vaccination In A Two-Dose Scheme In Girls Of 9-11 Years Old Compared To Bivalent Hpv 16/18 Vaccination In Ecuador And Challenges For Public Health And Screening, Maria-Isabel Roldos, Isabel Espinosa, Amit Kulkarni, Matthew Pillsbury, Andrew Pavelyev, Homero A. Monsanto, Diego Guarin, Miguel Cashat-Cruz
Publications and Research
Abstract
Aims: Assess the incremental cost-effectiveness of the quadrivalent HPV6/11/16/18 vaccination as administered in a two-dose scheme to girls between 9 and 11 years old, as compared to the bivalent HPV 16/18 vaccination administered in Ecuador, and to estimate the cost-saving of preventing GW while preventing cervical cancer with both vaccines.
Study Design: We used a previously developed transmission dynamic mathematical model to evaluate the impact of routine vaccination of 9-11 year-old females. The model assumed coverage of 90% for two doses of HPV6/11/16/18 vaccine at international price rates versus HPV16/18 vaccine and costs for genital warts treatment. Other simulation …
A Fully Liquid Dtap-Ipv-Hb-Prp-T Hexavalent Vaccine For Primaryand Booster Vaccination Of Healthy Turkish Infants And Toddlers, Mehmet Ceyhan, İnci̇ Yildirim, Hasan Tezer, İlker Devri̇m, Emmanuel Feroldi
A Fully Liquid Dtap-Ipv-Hb-Prp-T Hexavalent Vaccine For Primaryand Booster Vaccination Of Healthy Turkish Infants And Toddlers, Mehmet Ceyhan, İnci̇ Yildirim, Hasan Tezer, İlker Devri̇m, Emmanuel Feroldi
Turkish Journal of Medical Sciences
Background/aim: Immunogenicity and safety of a primary series of a fully liquid, hexavalent DTaP-IPV-HB-PRP-T vaccine given at 2, 3, and 4 months of age compared to licensed comparators and a DTaP-IPV-HB-PRP-T booster at 15?18 months were evaluated. Materials and methods: This was a Phase III, randomized, open-label trial. Primary series (no hepatitis B [HB] at birth) of DTaP-IPV-HB-PRP-T (N = 155) (group 1) or licensed control vaccines (DTaP-IPV//PRP-T and standalone HB: N = 155) (group 2) and DTaP-IPV-HB-PRP-T booster were administered. Noninferiority was evaluated 1 month postprimary series for anti-HB seroprotection (SP). All other analyses were descriptive. Safety was assessed …
Perceptions And Knowledge Of Influenza Vaccination Amongst University Students, Christian M. Martinez
Perceptions And Knowledge Of Influenza Vaccination Amongst University Students, Christian M. Martinez
Honors College Theses
Commonly known as “the flu”, influenza is a contagious respiratory infection that causes mild to severe illness. The CDC recommends annual influenza vaccination as the best method for prevention of the illness. This study was conducted to analyze university students’ perceptions and knowledge of influenza as well as influenza vaccination. A survey was completed by 284 Georgia Southern University students. This research found university students to possess basic knowledge of influenza and its implications for one’s health. However, the study found that university students lack some knowledge of influenza vaccination, and many university students did not seem to perceive influenza …
Vaccine-Preventable Disease Surveillance In Kentucky, Katherine Jay
Vaccine-Preventable Disease Surveillance In Kentucky, Katherine Jay
Theses and Dissertations--Public Health (M.P.H. & Dr.P.H.)
Background: Vaccine-preventable disease (VPD) surveillance is important component to the success of vaccines. This report examines the levels of 13 of these VPDs in the state of Kentucky from 2005 to 2015.
Methods: All reported cases in the state of Kentucky for the years 2005 to 2015 of 13 vaccine-preventable diseases were obtained from the Disease Surveillance Module (DSM) and the National Electronic Disease Surveillance System (NEDSS). Where enough cases were reported, descriptive statistics were prepared. For acute hepatitis B and pertussis, more thorough analysis was performed.
Results: Rates of acute hepatitis B in Kentucky from 2005 …
Evaluation Of Antibody Response To An Adjuvanted Hapten-Protein Vaccine As A Potential Inhibitor Of Sexual Maturation For Farmed Atlantic Salmon, Darcy S.O. Mora, Mo D. Salman, Christopher A. Myrick, Jack C. Rhyan, Lowell A. Miller, Ellen Marie Sætre, Douglas C. Eckery
Evaluation Of Antibody Response To An Adjuvanted Hapten-Protein Vaccine As A Potential Inhibitor Of Sexual Maturation For Farmed Atlantic Salmon, Darcy S.O. Mora, Mo D. Salman, Christopher A. Myrick, Jack C. Rhyan, Lowell A. Miller, Ellen Marie Sætre, Douglas C. Eckery
United States Department of Agriculture Wildlife Services: Staff Publications
An experimental contraceptive vaccine was evaluated in Atlantic salmon (Salmo salar). A peptide derived from the beta subunit of luteinizing hormone (LH) was conjugated to two different carrier proteins, bovine serum albumin (BSA) and keyhole limpet hemocyanin (KLH), and formulated with one of four immunostimulants in a water-in-oil emulsion. Specific antibody responses to the peptide and each carrier protein were evaluated. While the antibody response to KLH was stronger than the response to BSA, both carrier proteins stimulated comparable antibody responses to the LH peptide. The immunostimulant proved to be more important for enhancing the LH peptide antibody response …
Novel Possibilities For The Treatment And Prevention Of Cutaneous Leishmaniasis, Eva A. Iniguez
Novel Possibilities For The Treatment And Prevention Of Cutaneous Leishmaniasis, Eva A. Iniguez
Open Access Theses & Dissertations
Protozoan parasites from the genus Leishmania cause broad clinical manifestations known as leishmaniasis, which affect millions of people worldwide. Cutaneous leishmaniasis (CL) is mainly caused by either Leishmania major or L. tropica parasites, which produce localized cutaneous ulcers, often leading to scarring and social stigma. Currently, the disease has reached hyperendemicity levels in the Middle East due to conflict and human displacement and is one the most common forms of the disease in the Old World. Furthermore, the first choice of treatment in that region continues to be pentavalent antimonials, which are costly and highly toxic, and current vector control …
Examination Of Pseudomonas Fluorescence As A Recombinant Expression Host: Cloning, Expression, And Chromatography, Ahmed K.Ali Elmasheiti
Examination Of Pseudomonas Fluorescence As A Recombinant Expression Host: Cloning, Expression, And Chromatography, Ahmed K.Ali Elmasheiti
Graduate Theses and Dissertations
In an effort to expand the pool of bacterium useful for biotechnology applications, Pseudomonas fluorescens, a common gram negative microbe, was examined for its ability to function in a recombinant setting. P. fluorescens is ubiquitous in nature and was initially identified as a soil bacterium found in dirt and is typically associated with plant material. Past literature indicates that it shared characteristics common to Escherichia coli and Bacillus subtilis, including simple growth conditions and potential cloning vectors, providing motivation to look into both the upstream and downstream characteristics of this bacterium. First, it was demonstrated that P. fluorescens could be …
Rickettsiologist Pavel F. Zdrodovskii: Larger Than Life, And Not Just For His Famous Book, Marina E. Eremeeva, S. N. Shpynov, I. V. Tarasevich
Rickettsiologist Pavel F. Zdrodovskii: Larger Than Life, And Not Just For His Famous Book, Marina E. Eremeeva, S. N. Shpynov, I. V. Tarasevich
Environmental Health Sciences: Faculty Publications
This article highlights the biography and scientific accomplishments of Pavel F. Zdrodovskii and his contributions to understanding the biology, pathogenesis, treatment, prevention and epidemiology of brucellosis, rickettsioses and many other infectious diseases.
Utilization Of Cholera Toxin B As An Adjuvant For The Subunit Pspa Vaccine, Provides Effective Protection Against Streptococcus Pneumoniae Challenge, Daniel R. Pinho
Utilization Of Cholera Toxin B As An Adjuvant For The Subunit Pspa Vaccine, Provides Effective Protection Against Streptococcus Pneumoniae Challenge, Daniel R. Pinho
Seton Hall University Dissertations and Theses (ETDs)
Streptococcus pneumoniae is a prevalent human pathogen associated with pneumonia. It is estimated that approximately 1 million people around the world die each year, specifically with young children and the elderly comprising a significant portion. Currently, antibiotics can treat the infection but individuals such as the young or elderly are more susceptible to bodily damage from symptoms, such as pneumonia, meningitis, and sepsis, thus require more preventive measures. As a result, vaccinations are a key solution to providing effective protection against infectious pathogens. Presently, two vaccinations exist in the market: PPSV23 and PCV13, which only protect against …
Assessment Of The Level Of Protection Against Coccidiosis In Broiler Breeders Conferred By A Live Anticoccidial Vaccine, And Its Influence On Early Growth And Development., Muhammed Shameer Abdul Rasheed
Assessment Of The Level Of Protection Against Coccidiosis In Broiler Breeders Conferred By A Live Anticoccidial Vaccine, And Its Influence On Early Growth And Development., Muhammed Shameer Abdul Rasheed
Graduate Theses and Dissertations
Coccidiosis continues to be a great challenge to the poultry industry all over the world and in broiler breeders vaccination with live oocysts of Eimeria has been widely adopted as a control measure. Broiler breeders are usually subjected to feed restriction during their early growth however no studies have been undertaken on the effects of vaccination in birds whose feed has been restricted in this manner. The objective of this study was to assess the level of protection acquired by broiler breeder chickens when immunized at day-old with live eimerian oocysts and given a restricted diet. Effects upon growth and …
A Randomized, Double-Blind, Placebo-Controlled Phase Ii Trial Investigating The Safety And Immunogenicity Of Modified Vaccinia Ankara Smallpox Vaccine (Mva-Bn®) In 56-80-Year-Old Subjects, Richard N. Greenberg, Christine M. Hay, Jack T. Stapleton, Thomas C. Marbury, Eva Wagner, Eva Kreitmeir, Siegfried Röesch, Alfred Von Krempelhuber, Philip Young, Richard Nichols, Thomas P. Meyer, Darja Schmidt, Josef Weigl, Garth Virgin, Nathaly Arndtz-Wiedemann, Paul Chaplin
A Randomized, Double-Blind, Placebo-Controlled Phase Ii Trial Investigating The Safety And Immunogenicity Of Modified Vaccinia Ankara Smallpox Vaccine (Mva-Bn®) In 56-80-Year-Old Subjects, Richard N. Greenberg, Christine M. Hay, Jack T. Stapleton, Thomas C. Marbury, Eva Wagner, Eva Kreitmeir, Siegfried Röesch, Alfred Von Krempelhuber, Philip Young, Richard Nichols, Thomas P. Meyer, Darja Schmidt, Josef Weigl, Garth Virgin, Nathaly Arndtz-Wiedemann, Paul Chaplin
Internal Medicine Faculty Publications
Background Modified Vaccinia Ankara MVA-BN® is a live, highly attenuated, viral vaccine under advanced development as a non-replicating smallpox vaccine. In this Phase II trial, the safety and immunogenicity of Modified Vaccinia Ankara MVA-BN® (MVA) was assessed in a 56–80 years old population.
Methods MVA with a virus titer of 1 x 108 TCID50/dose was administered via subcutaneous injection to 56–80 year old vaccinia-experienced subjects (N = 120). Subjects received either two injections of MVA (MM group) or one injection of Placebo and one injection of MVA (PM group) four weeks apart. Safety was evaluated …
Hiv Vaccines: Progress, Limitations And A Crispr/Cas9 Vaccine, Omar A. Garcia Martinez
Hiv Vaccines: Progress, Limitations And A Crispr/Cas9 Vaccine, Omar A. Garcia Martinez
Biology: Student Scholarship & Creative Works
ABSTRACT: The HIV-1 pandemic continues to thrive due to ineffective HIV-1 vaccines. Historically, the world’s most infectious diseases, such as polio and smallpox, have been eradicated or have come close to eradication due to the advent of effective vaccines. Highly active antiretroviral therapy is able to delay the onset of AIDS but can neither rid the body of HIV-1 proviral DNA nor prevent further transmission. A prophylactic vaccine that prevents the various mechanisms HIV-1 has to evade and attack our immune system is needed to end the HIV-1 pandemic. Recent advances in engineered nuclease systems, like the CRISPR/Cas9 system, have …
Viruses, Vaccines And The Public, Judy Diamond, Julia Mcquillan, Amy Spiegel, Patricia Wonch Hill, Rebecca Smith, John T. West, Charles Wood
Viruses, Vaccines And The Public, Judy Diamond, Julia Mcquillan, Amy Spiegel, Patricia Wonch Hill, Rebecca Smith, John T. West, Charles Wood
World of Viruses
Current research in virology is changing public conceptions about vaccines and infectious disease. The University of Nebraska State Museum collaborated with research virologists, science writers, artists and learning researchers to create public outreach materials about viruses and infectious disease. The project, funded by the National Institute of Health’s SEPA program, developed comics, a book with Carl Zimmer, and other materials and programs. The project launched three kinds of learning research: 1) a survey of Nebraska adults on their opinions about vaccines and infectious disease; 2) a study comparing the mental models of viruses, vaccines and infection from virologists, teachers, and …
Pulmonary Bcg Vaccination For Uniform Protection Against Tuberculosis In Environmental Mycobacteria Endemic Regions, Dominique Nicole Price
Pulmonary Bcg Vaccination For Uniform Protection Against Tuberculosis In Environmental Mycobacteria Endemic Regions, Dominique Nicole Price
Biomedical Sciences ETDs
Currently, over one-third of the global population is infected with tuberculosis (TB), one of the world's most deadly infectious diseases. The current vaccine against TB, Bacille Calmette-Guérin (BCG), is a live attenuated vaccine that is intradermally administered in over 150 countries around the world. Despite its widespread use, the vaccine has a variable protective efficacy of 0-80%, with the lowest efficacy rates in regions of the world where TB is most prevalent. This variability is partially due to environmental mycobacteria (EM) found in soil and water sources in areas of the world where BCG efficacy is poor. The research hypothesis …
Bacteriophage Virus-Like Particles As Vaccine Platforms: From Heart Disease To Malaria, Erin Crossey
Bacteriophage Virus-Like Particles As Vaccine Platforms: From Heart Disease To Malaria, Erin Crossey
Biomedical Sciences ETDs
Virus-like particles (VLPs) make excellent vaccines. They are non-infectious, often easy to produce in bacterial expression systems, and highly immunogenic. The latter feature is granted by the regularity of the capsid structure, which presents viral (or other) epitopes as dense, highly repetitive arrays that strongly stimulate B cells. VLPs can be used as the basis for vaccines targeting the virus from which they were derived, or they can be used as platforms to display practically any short peptide epitope in a multivalent format. Foreign peptides displayed on VLPs exhibit the same high immunogenicity as unmodified VLPs. Even self-antigens, normally subject …
Characterization Of Induced Rnai Silencing Of Vaccinia Virus Essential Genes, Kewa Jiang
Characterization Of Induced Rnai Silencing Of Vaccinia Virus Essential Genes, Kewa Jiang
Honors Scholar Theses
Vaccinia virus (VACV) is a large double-stranded DNA virus and the prototypical member of the family Poxviridae and is most notable for its use as the vaccine that eradicated smallpox (variola virus). More recently, VACV has been used to develop recombinant vaccines and immunotherapies. However, many of these processes require VACV replication to be tightly controlled. RNA interference (RNAi) is a powerful tool for in vitro silencing of mRNAs that are complementary to 19-21 base pairs (bp) of double-stranded RNA (dsRNA). This project outlines the design and preliminary analysis of two inducible RNAi silencing constructs targeting multiple VACV essential genes …
Affecting Tdap Vaccination Rates Among Women: A Multifaceted Intervention, Soneka Wynter
Affecting Tdap Vaccination Rates Among Women: A Multifaceted Intervention, Soneka Wynter
Evidence-Based Practice Project Reports
Despite the availability of a preventive vaccine, the incidence of pertussis in the United States has continued to increase over the past two decades and it is now considered the most common preventable infectious illness. Highly contagious in nature, it is estimated that about 50 million people are infected each year, and approximately 300,000 deaths occur worldwide (Centers for Disease Control and Prevention [CDC], 2012). In 2013, Indiana reported 616 cases (Indiana State Department of Health [ISDH], 2014). In spite of CDC recommendations on strategies that can improve vaccine delivery, rates of immunization remain low nationwide (CDC, 2014). The purpose …
Investigating The Effects Of Increasing Anti-Ama1, Anti-Msp1, And Anti-Msp2 In Preventing Malaria Incidence, April Skipper
Investigating The Effects Of Increasing Anti-Ama1, Anti-Msp1, And Anti-Msp2 In Preventing Malaria Incidence, April Skipper
Selected Honors Theses
Malaria is a life-threatening illness that 3.2 billion people, half of the world's population, are at risk of contracting. In 2015, there were 214 million malaria cases and 438,000 deaths caused by the disease. It is caused by Plasmodium parasites which infect humans through the bite of the Anopheles mosquito. The four species of Plasmodium that are known to cause malaria are P. falciparum, P. vivax, P. ovale, P. malariae, and P. knowlesi. The symptoms of malaria greatly resemble symptoms of a common cold, so accurate diagnosis can be a challenge. Symptoms commonly include fever, headache, …
Vaccines And The Looming Threat Of Syphilis, Charles T. Ambrose
Vaccines And The Looming Threat Of Syphilis, Charles T. Ambrose
Microbiology, Immunology, and Molecular Genetics Faculty Publications
During the past several decades, syphilis has increased in the US and explosively so in China and Russia.While most current cases can be cured by penicillin or second line antibiotics, strains of the syphilis spirochete (Treponema pallidum) resistant to the latter have emerged.And the potential of strains to acquire resistance to penicillin via plasmids has recently been recognized.The 36 million-plus undertreated cases of syphilis in the world represent metaphorically a vast global 37°C incubator allowing exchange of antibiotic resistant genes among the human-borne bacteria and theoretically permitting the emergence of penicillin resistant strains.None has yet been identified but …
Leveraging Contact Network Structure In The Design Of Cluster Randomized Trials, Guy Harling, Rui Wang, Jukka-Pekka Onnela, Victor Degruttola
Leveraging Contact Network Structure In The Design Of Cluster Randomized Trials, Guy Harling, Rui Wang, Jukka-Pekka Onnela, Victor Degruttola
Harvard University Biostatistics Working Paper Series
Background: In settings like the Ebola epidemic, where proof-of-principle trials have succeeded but questions remain about the effectiveness of different possible modes of implementation, it may be useful to develop trials that not only generate information about intervention effects but also themselves provide public health benefit. Cluster randomized trials are of particular value for infectious disease prevention research by virtue of their ability to capture both direct and indirect effects of intervention; the latter of which depends heavily on the nature of contact networks within and across clusters. By leveraging information about these networks – in particular the degree …
Bait Flavor Preference And Immunogenicity Of Onrab Baits In Domestic Dogs On The Navajo Nation, Arizona, Are R. Berentsen, Scott Bender, Peggy Bender, David Bergman, Amy T. Gilbert, Hannah M. Rowland, Kurt C. Vercauteren
Bait Flavor Preference And Immunogenicity Of Onrab Baits In Domestic Dogs On The Navajo Nation, Arizona, Are R. Berentsen, Scott Bender, Peggy Bender, David Bergman, Amy T. Gilbert, Hannah M. Rowland, Kurt C. Vercauteren
United States Department of Agriculture Wildlife Services: Staff Publications
Rabies is responsible for an estimated 59,000 human deaths worldwide, and domestic dogs are the primary reservoir and vector of the disease. Among some nations, widespread vaccination has led to elimination of rabies in domestic dogs, yet dogs are still susceptible to rabies infection from interactions with wildlife reservoirs. On Tribal lands in the United States, less than 20% of domestic dogs are vaccinated for rabies, and parenteral vaccination is often unfeasible. Oral rabies vaccination may provide a solution, but a suitable bait flavor and vaccine must be identified. We evaluated 5 bait flavors (bacon, cheese, egg, fish, and sweet) …
Antibody-Mediated Immunity To Vibrio Cholerae At Epithelial Surfaces, Kara Jeanette Levinson
Antibody-Mediated Immunity To Vibrio Cholerae At Epithelial Surfaces, Kara Jeanette Levinson
Legacy Theses & Dissertations (2009 - 2024)
Vibrio cholerae, the causative agent of the severe diarrheal disease cholera, has an estimated worldwide disease burden in the millions and remains a significant public health threat. Immunity to V. cholerae is primarily antibody-mediated and though V. cholerae colonization evokes a mucosal immune response, it is the secretory IgA (SIgA) antibodies produced against bacterial surface antigens, specifically lipopolysaccharide (LPS) that confer protective immunity. SIgA antibodies are thought to function by inhibiting colonization by cross-linking and agglutination of pathogens, thereby limiting access to the epithelium, a process known as immune exclusion. Recent studies in other enteric pathogens have demonstrated that SIgA …
Enhancement Of Cancer Vaccine Efficacy Via Nanoparticle Or Molecular-Based Adjuvants, Myunggi An
Enhancement Of Cancer Vaccine Efficacy Via Nanoparticle Or Molecular-Based Adjuvants, Myunggi An
Wayne State University Theses
Adjuvants are immunomodulators which enhance immune responses to vaccines. However, parenteral administration of unformulated adjuvants fails to reach lymph nodes (LNs), the anatomic organ where the primary functions of immune cells are orchestrated. The LN-targeting delivery plays the key roles in promoting immune activation and has the great potential to transform disease treatment. The main goal of this thesis is to develop efficient vaccine delivery systems to target therapeutics into draining lymph nodes (dLNs) for ensuring their immunostimulatory activity. We introduced therapeutic applications of activating TLR9 with synthetic CpG oligodeoxynucleotide (ODN) agonists in nanoparticle or molecular form to activate immune …
Purification Of Avian Influenza Virus (H9n2) From Allantoic Fluidby Size-Exclusion Chromatography, Ali Nazari Shirvan, Maedeh Samianifard, Naser Ghodsian
Purification Of Avian Influenza Virus (H9n2) From Allantoic Fluidby Size-Exclusion Chromatography, Ali Nazari Shirvan, Maedeh Samianifard, Naser Ghodsian
Turkish Journal of Veterinary & Animal Sciences
Avian influenza viruses represent a rising threat of pandemic influenza. Allantoic fluid including influenza virus H9N2 was run on downstream processing to purify the virus. To do this, allantoic fluid was clarified and concentrated. It was applied to size exclusion chromatography. Different parameters such as ovalbumin, protein content, and hemagglutinin activity were determined to confirm the purity. The results may suggest that this method is quite efficient for achieving a purified H9N2 influenza virus and further reveal that size-exclusion chromatography is a practical method for purifying avian influenza viruses. In conclusion, this procedure can be used in vaccine production and …